Skip to content

Absci Corporation ABSI Debt Securities, Available-for-Sale, Amortized Cost, Excluding Accrued Interest, after Allowance for Credit Loss

Debt Securities, Available-for-Sale, Amortized Cost, Excluding Accrued Interest, after Allowance for Credit Loss at other companies

BioCryst Pharmaceuticals logo
BioCryst PharmaceuticalsBCRX

Other financials

Income statement

See full
Revenue$215.0K-81.8%
Operating income-$30.8M-11.2%
Net income-$29.6M-12.3%
EPS (diluted)-$0.19+9.5%

Balance sheet

See full
Cash & equivalents$9.7M-84.9%
Total debt$4.0M-37.2%
Total equity$172.0M-13.5%
Total assets$195.6M-15.9%

Cash flow

See full
Operating cash flow-$26.3M-20.5%
CapEx$30.0K+20.0%
Free cash flow-$26.3M-20.5%

Valuation

See full
Market cap$1.57B+341%
Enterprise value$1.57B+425%
P/S855.5×+782×

Profitability

See full
Operating margin-6,723%-14,525pp
Net margin-6,450.8%-13,699pp
FCF margin-5,365.2%-9,300pp

Returns & leverage

See full
Return on equity-63.9%+28.0pp
Debt / equity0.0×
Current ratio6.6×+0.9×

Where this comes from

Reported directly by Absci Corporation in its filing.

Tagged under the XBRL concept us-gaap:DebtSecuritiesAvailableForSaleAmortizedCostExcludingAccruedInterestAfterAllowanceForCreditLoss.

The official record: Absci Corporation’s 10-Q, filed May 7, 2026, on SEC EDGAR. View the filing →

Ask your AI about Absci Corporation's debt securities, available-for-sale, amortized cost, excluding accrued interest, after allowance for credit loss.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Absci Corporation's debt securities, available-for-sale, amortized cost, excluding accrued interest, after allowance for credit loss?
Absci Corporation (ABSI) reported debt securities, available-for-sale, amortized cost, excluding accrued interest, after allowance for credit loss of $122.78M in Q1 2026.
How has Absci Corporation's debt securities, available-for-sale, amortized cost, excluding accrued interest, after allowance for credit loss changed year-over-year?
Absci Corporation's debt securities, available-for-sale, amortized cost, excluding accrued interest, after allowance for credit loss increased by 41.1% year-over-year, from $86.98M to $122.78M.
What is the long-term trend for Absci Corporation's debt securities, available-for-sale, amortized cost, excluding accrued interest, after allowance for credit loss?
Over 3 years (2022 to 2025), Absci Corporation's debt securities, available-for-sale, amortized cost, excluding accrued interest, after allowance for credit loss has grown at a 8.1% compound annual growth rate (CAGR), from $109.57M to $138.47M.